Jason Schwartz is an assistant professor in the Department of Health Policy and Management at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.

The bibliographic file:

Dr. Jason Schwartz . (2020). Interview with Dr. Jason Schwartz on processes for determining the safety and efficacy of Covid-19 vaccine candidates and for distributing vaccines.. 2020, de Managing Editor of the Journal Sitio web: https://www.nejm.org/action/showMediaPlayer?doi=10.1056%2FNEJMdo005882&aid=10.1056%2FNEJMp2029479&viewType=Popup&viewClass=Audio&ctype=audiointerview&area=production

New resistance-busting antibiotic combination could extend the use of ‘last-resort’ antibiotics

Science Daily recently published an article on…

‘Living medicine’ created to treat drug-resistant infections

Researchers at the Centre for Genomic Regulation…

FDA ajusta la “fórmula” de Kisunla para hacerlo más seguro

La FDA aprobó un cambio en las instrucciones de…

Comprendiendo la diabetes tipo 5: causas, características y a quiénes afecta

La Federación Internacional de Diabetes (FDI)…

Antibiotic combinations may boost resistance, study finds

Becker’s Hospital Review recently reported on a…

Knee replacement in folks over 80: Less risky than you think

Knee replacement in folks over 80: Less risky…

La resistencia a los antibióticos puede extenderse en ausencia de medicamentos.

Medical News Today informó recientemente sobre…

Por qué la resistencia a los antibióticos es más preocupante que nunca

Susan Brink, una escritora independiente para…

ISASS 2021 – The International Society for the Advancement of Spine Surgery

2021-05-13 – 2021-05-15 / English / Congress…

Exudado post artroplastias y uso de STIMULAN

Después de una artroplastia,…